Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatitis B virus and pathogenesis]

P J Grob1, P C Frei

  • 1Abteilung für Klinische Immunologie, Universitätsspital, Zürich.

Sozial- Und Praventivmedizin
|December 2, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered intracellular expression of the chemokines MIP-1alpha, MIP-1beta and IL-8 by peripheral blood CD4+ and CD8+ T cells in mild allergic asthma.

Allergy·2003
Same author

Presence of low levels of anti-HBs antibody in so-called 'anti-HBc alone' subjects.

Liver·2002
Same author

[Hepatitis B virus infection: diagnosis, clinical sequelae, therapy and prevention].

Praxis·2002
Same author

Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection.

Journal of acquired immune deficiency syndromes (1999)·2001
Same author

Absence of anti-hepatitis B surface antibody after vaccination does not necessarily mean absence of immune response.

Medical microbiology and immunology·2001
Same author

Isolated antibody to hepatitis B core is associated with hepatitis C virus co-infection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2001
Same journal

Time trends in cancer mortality in central Serbia.

Sozial- und Praventivmedizin·2007
Same journal

Findings from the Global Youth Tobacco Survey (GYTS) in Czech Republic, Hungary, Poland and Slovakia--smoking initiation, prevalence of tobacco use and cessation.

Sozial- und Praventivmedizin·2007
Same journal

Reference values for serum lipids and lipoproteins in Spanish adolescents: the AVENA study.

Sozial- und Praventivmedizin·2007
Same journal

Tobacco use among youth and related characteristics, Turkey.

Sozial- und Praventivmedizin·2007
Same journal

Adolescents' education and their diet recorded by 7-day food records.

Sozial- und Praventivmedizin·2007
Same journal

Towards the end of the Spanish paradox?

Sozial- und Praventivmedizin·2007
See all related articles

Hepatitis B virus (HBV) infection outcomes vary based on the balance between viral replication and immune response. Effective vaccines target the HBs surface antigen (HBsAg), preventing infection by inducing anti-HBs antibodies.

Area of Science:

  • Virology
  • Immunology
  • Hepatology

Context:

  • Hepatitis B virus (HBV), a hepadnavirus with a partially double-stranded DNA genome, primarily infects hepatocytes.
  • HBV replication occurs in the cytoplasm and is generally non-cytopathogenic, though viral integration into host cells can happen.
  • Distinct HBV genotypes and subtypes exhibit specific geographic distributions.

Purpose:

  • To elucidate the molecular mechanisms and immune responses governing Hepatitis B virus infection.
  • To understand the variability in clinical outcomes, from viral clearance to chronic disease progression.
  • To highlight the role of cellular immunity in controlling HBV infection.

Summary:

  • The Hepatitis B virus (HBV) genome encodes structural proteins, including the HBs surface antigen (HBsAg), and regulatory enzymes.

Related Experiment Videos

  • HBV infection involves cytoplasmic replication and potential host cell integration, with diverse genotypes influencing epidemiology.
  • A globally effective vaccine targets HBsAg, inducing protective anti-HBs antibodies.
  • Elimination of HBV relies on cellular immune mechanisms, including cytotoxic T lymphocytes, macrophages, and interferon-gamma.
  • The clinical course of HBV infection is determined by the interplay between viral replication and host immune defenses, potentially leading to chronic hepatitis, cirrhosis, and hepatocellular carcinoma.

    • Impact:

    • Understanding HBV pathogenesis is crucial for developing novel therapeutic strategies beyond vaccination.
    • Identifying the determinants of immune control can inform the management of chronic Hepatitis B.
    • This knowledge aids in predicting disease progression and patient outcomes, including the risk of liver cancer.